Clinical Trial Update: N-acetylcysteine and NMDA Antagonist Interactions [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trials evaluating interactions between N-acetylcysteine and NMDA receptor antagonists in cognitive dysfunction have completed. Results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• NMDA receptor antagonist (NMDA receptor antagonist)

Snippet

Sponsor: Yale University | Conditions: Cognitive Dysfunction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-05-08